Additionally, we conducted supplementary IF staining involving triple labeling with ox-LDL, the mesangial cell nuclear marker GATA3, and the membrane protein marker PDGFRβ to examine whether ox-LDL was present in mesangial cells under DKD conditions (Fig. 1E). This evidence concerns the gene GATA3 and diabetic kidney disease.